Faes Farma Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Faes Farma has a total shareholder equity of €686.0M and total debt of €47.4M, which brings its debt-to-equity ratio to 6.9%. Its total assets and total liabilities are €837.5M and €151.5M respectively. Faes Farma's EBIT is €109.7M making its interest coverage ratio 211.4. It has cash and short-term investments of €69.8M.
Anahtar bilgiler
6.9%
Borç/özkaynak oranı
€47.44m
Borç
| Faiz karşılama oranı | 211.4x |
| Nakit | €69.84m |
| Eşitlik | €686.01m |
| Toplam yükümlülükler | €151.52m |
| Toplam varlıklar | €837.53m |
Son finansal sağlık güncellemeleri
Does Faes Farma (BME:FAE) Have A Healthy Balance Sheet?
Nov 24
Here's Why Faes Farma (BME:FAE) Can Manage Its Debt Responsibly
May 03Is Faes Farma (BME:FAE) A Risky Investment?
Aug 03Is Faes Farma (BME:FAE) Using Too Much Debt?
Mar 27Is Faes Farma (BME:FAE) A Risky Investment?
Sep 21Is Faes Farma (BME:FAE) Using Too Much Debt?
May 01Recent updates
Faes Farma, S.A. (BME:FAE) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Nov 03Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think
Mar 01Faes Farma (BME:FAE) Is Due To Pay A Dividend Of €0.0316
Dec 18Faes Farma (BME:FAE) Will Pay A Dividend Of €0.0316
Dec 04Does Faes Farma (BME:FAE) Have A Healthy Balance Sheet?
Nov 24Here's Why Faes Farma (BME:FAE) Can Manage Its Debt Responsibly
May 03Is There An Opportunity With Faes Farma, S.A.'s (BME:FAE) 50% Undervaluation?
Sep 21Is Faes Farma (BME:FAE) A Risky Investment?
Aug 03Faes Farma (BME:FAE) Ticks All The Boxes When It Comes To Earnings Growth
Jun 17Is Faes Farma (BME:FAE) Using Too Much Debt?
Mar 27Faes Farma (BME:FAE) Is Increasing Its Dividend To €0.14
Dec 13Faes Farma's (BME:FAE) Dividend Will Be Increased To €0.17
Nov 29Is Faes Farma (BME:FAE) A Risky Investment?
Sep 21Faes Farma, S.A. (BME:FAE) Interim Results: Here's What Analysts Are Forecasting For This Year
Jul 31Is Faes Farma (BME:FAE) Using Too Much Debt?
May 01Estimating The Fair Value Of Faes Farma, S.A. (BME:FAE)
Apr 07Does Faes Farma, S.A. (BME:FAE) Have A Place In Your Dividend Portfolio?
Mar 22Faes Farma's (BME:FAE) Solid Earnings May Rest On Weak Foundations
Mar 06Faes Farma (BME:FAE) Has Compensated Shareholders With A Respectable 61% Return On Their Investment
Feb 22I Ran A Stock Scan For Earnings Growth And Faes Farma (BME:FAE) Passed With Ease
Jan 16Faes Farma (BME:FAE) Seems To Use Debt Rather Sparingly
Dec 08Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: FAE's short term assets (€346.9M) exceed its short term liabilities (€126.6M).
Uzun Vadeli Yükümlülükler: FAE's short term assets (€346.9M) exceed its long term liabilities (€24.9M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: FAE has more cash than its total debt.
Borcun Azaltılması: FAE's debt to equity ratio has increased from 3.2% to 6.9% over the past 5 years.
Borç Kapsamı: FAE's debt is well covered by operating cash flow (222.6%).
Faiz Kapsamı: FAE's interest payments on its debt are well covered by EBIT (211.4x coverage).